Japer Therapeutics Warrants
JSPRW
8 hedge funds and large institutions have $1.09M invested in Japer Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
185% more capital invested
Capital invested by funds: $383K → $1.09M (+$709K)
33% more funds holding
Funds holding: 6 → 8 (+2)
20.51% less ownership
Funds ownership: 20.51% → 0% (-21%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$30.4K |
| 2 |
CS
Clear Street
New York
|
+$10 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZA
Zazove Associates
Incline Village,
Nevada
|
-$6.21K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$213 |
JSPRW Hedge Fund Activity: Q3 2025 in Review
8 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q3 2025, worth a combined $1.09M — up 185% from $383K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new JSPRW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $30.4K. The largest seller was Zazove Associates, exiting entirely with an estimated $6.21K sold.
- 8 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q3 2025, up from 6 in Q2 2025.
- Funds reported $1.09M of Japer Therapeutics Warrants stock for Q3 2025, up 185% quarter-over-quarter.
- 3 funds opened new Japer Therapeutics Warrants positions in Q3 2025 and 1 closed out, a net change of +2 holders.
- The largest Japer Therapeutics Warrants buyer in Q3 2025 was Boothbay Fund Management, an estimated $30.4K added.
- The largest Japer Therapeutics Warrants seller in Q3 2025 was Zazove Associates, an estimated $6.21K sold.
Based on aggregated 13F filings for Q3 2025.